---
title: Modulation of Human Thrombopoietin Receptor Conformations Uncouples JAK2 V617F-Driven
  From Cytokine-Induced Activation
date: '2023-08-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37616564/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20230825181045&v=2.17.9.post6+86293ac
source: Blood
description: The Thrombopoietin Receptor (TpoR) is a central player in Myeloproliferative
  Neoplasms (MPNs). Mutations in JAK2, calreticulin or in TpoR itself drive constitutive
  activation of TpoR and uncontrolled proliferation and differentiation of hematopoietic
  stem cells and progenitors. The JAK2 V617F mutation is responsible for the majority
  of MPNs and all driver mutants induce pathologic TpoR activation. Existing therapeutic
  strategies have focused on JAK2 kinase inhibitors that are unable ...
disable_comments: true
---
The Thrombopoietin Receptor (TpoR) is a central player in Myeloproliferative Neoplasms (MPNs). Mutations in JAK2, calreticulin or in TpoR itself drive constitutive activation of TpoR and uncontrolled proliferation and differentiation of hematopoietic stem cells and progenitors. The JAK2 V617F mutation is responsible for the majority of MPNs and all driver mutants induce pathologic TpoR activation. Existing therapeutic strategies have focused on JAK2 kinase inhibitors that are unable ...